Searchable abstracts of presentations at key conferences on calcified tissues
Bone Abstracts (2014) 3 PP13 | DOI: 10.1530/boneabs.3.PP13

Arthritis and other joint diseases: translational and clinical

RANK expression is reduced in circulating monocytes from ankylosing spondylitis patients

Inês Pedro Perpetuo1, Joana Caetano-Lopes1, Elsa Vieira-Sousa1,2, Raquel Campanilho-Marques1,2, Cristina Ponte1,2, Helena Canhao1,2, Mari Ainola3 & Joao Eurico Fonseca1,2

72 views


1JE Fonseca Lab (Rheumatology Research Unit), Instituto de Medicina Molecular, Lisbon Academic Medical Centre, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal; 2Rheumatology and Bone Metabolic Diseases Department, Lisbon Academic Medical Centre, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, EPE, Lisboa, Portugal; 3Musculoskeletal Diseases and Inflammation Research Group, Biomedicum Helsinki, Faculty of Medicine, Institute of Clinical Medicine, University of Helsinki, Helsinki, Finland.


Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are systemic, immune-mediated diseases. RA’s main targets are the peripheral joints while AS has the axial skeleton and enthesis as the principal affected areas. RA is characterized by bone erosions and impaired repair whilst AS is typified by bone overgrowth. The causes for these differences are not yet understood; however we hypothesize that AS patients’ monocytes receive reduced osteoclastogenic stimuli and/or have abnormal capacity to respond to them.

The aim of this study was to characterize AS patients’ bone remodeling and pro osteoclastogenesis inflammatory environment and monocyte phenotypes as compared to RA patients and healthy controls.

Untreated AS or RA patients with active disease and age and gender-matched healthy donors were recruited for this study. Blood was collected for flow cytometry measurements of RANKL expression and monocyte subpopulation characterization. Serum was collected for cytokine and bone remodeling factors quantification. This study was approved by the hospital’s ethics committee.

We found that RANKL lymphocyte expression was higher in AS and RA patients when compared to healthy donors. However, both in classical and intermediate monocyte subpopulations RANK expression was lower in AS patients as compared to RA patients and healthy controls. In accordance, CTX-I serum level was also lower in AS patients than in healthy controls.

Conclusion: Despite comparable osteoclastogenic stimuli in AS and RA patients, RANK expression is reduced in AS circulating monocytes which may contribute to the bone forming phenotype observed in AS patients.

Volume 3

European Calcified Tissue Society Congress 2014

Prague, Czech Republic
17 May 2014 - 20 May 2014

European Calcified Tissue Society 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts

No recent abstracts.